PD36-01 IMPROVED PATIENT-REPORTED OUTCOMES (PROS) WITH MIRABEGRON ADD-ON TREATMENT IN A RANDOMIZED, DOUBLE-BLIND, PHASE 3B STUDY IN INCONTINENT OVERACTIVE BLADDER (OAB) PATIENTS WITH AN INADEQUATE RESPONSE TO SOLIFENACIN

Authors :: Marcus J. Drake
Moses Huang
Claire Hemsted
Jack Barkin
Emad Siddiqui
Matthias Stölzel
Aino Fianu-Jonasson
Salman Al-Shukri
Philippe Grise
Scott MacDiarmid
Sender Herschorn
Source :: Journal of Urology. 195
Publication Year :: 2016
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2016.

Subjects :: Double blind
medicine.medical_specialty
Solifenacin
Add on treatment
Overactive bladder
business.industry
Urology
medicine
Mirabegron
business
medicine.disease
medicine.drug

Full Text Access

Tools